K.C. Brennan

John Rose, MD, is Neuroimmunology & Autoimmune Neurology Division Chief and Professor of Neurology at the University of Utah, and is chief of neurology at the Salt Lake City Veterans Administration Hospital. Dr. Rose and his colleagues investigate diverse aspects of multiple sclerosis (MS), including the immunopathology of MS and related models, the development of new treatments for MS, early disease detection with advanced magnetic resonance imaging, and the detection of susceptibility genes for MS. Dr. Rose's focus is on multiple sclerosis clinical care and research. His clinic is a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center. There are ongoing clinical investigations of neurogenic pain, OCT, and immunotherapies. One special area of research is Pediatric Multiple Sclerosis, including clinical and translational investigations. Another important area is development of Magnetic Resonance Imaging for detection of demyelination and remyelination. Dr. Rose sees patients at University of Utah, a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center. His favorite sport is lacrosse.

Christine Cliatt Brown, MD, is a Behavioral Neurologist and assistant professor in the Division of Cognitive Neurology. She specializes in the diagnosis and treatment of various types of dementia, such as Frontotemporal Dementia, Dementia with Lewy Bodies, Alzheimer’s Disease, and others. She has particular interest in young-onset dementia, Primary Progressive Aphasia, familial Frontotemporal Dementia, Normal Pressure Hydrocephalus, and atypical presentations of dementia. Her mission in clinical practice is to help provide her patients and their families with answers and a better understanding of the diseases they face. Dr. Cliatt Brown received her medical degree from the University of Colorado School of Medicine. She completed her internship in internal medicine and residency training in neurology at the University of Utah. She then went on to do a fellowship in Behavioral Neurology at Mayo Clinic in Rochester, Minnesota. At Mayo Clinic, her research focused on anomia in Primary Progressive Aphasia and visual hallucinations in Dementia with Lewy Bodies. After completion of her fellowship, she returned to the University of Utah. One of her primary goals is to help train a new generation of neurologists who understand the complexities and nuances in dementia diagnosis and treatment. Conditions Treated: • Alzheimer’s Disease • Frontotemporal Dementia • Dementia with Lewy Bodies • Primary Progressive Aphasia • Primary Progressive Apraxia of Speech • Corticobasal Degeneration • Progressive Supranuclear Palsy • Posterior Cortical Atrophy • Normal Pressure Hydrocephalus • Young-onset dementia • Mild Cognitive Impairment

Melissa Cortez, DO, is a neurologist who has specialized expertise in neurological diseases affecting the autonomic nervous system (autonomic neurology), as well as multiple sclerosis (MS). She is board certified in neurology and clinical neurophysiology (EMG, nerve conduction studies, evoked potentials, and autonomic testing). Dr. Cortez is the director and founder of the autonomic physiology lab at the University of Utah and has integrated a research program into her clinical work, aiming to better understand the underlying physiology of symptoms her patients experience. This knowledge is aimed at improving diagnostic strategies, improved selection of treatment options, and improving outcomes.